Current Value of Holding

$398M

Shares

12.1M

% of Portfolio

2.66%

Average Buy Price

$55.1

Avg closing price
Price range

22 Cathie Wood Beam Therapeutics Trades

Cathie Wood's position in Beam Therapeutics is currently worth $398M. That's 2.66% of their equity portfolio (11th largest holding). The investor owns 11.76% of the outstanding Beam Therapeutics stock. The first Beam Therapeutics trade was made in Q4 2020. Since then Cathie Wood bought shares fourteen more times and sold shares on seven occasions. The investor's estimated purchase price is $669M, resulting in a loss of 40%.

Avg closing price
Price range
Sold 2.7% shares (-334k shares) Q1 2026
Avg closing price $28.56
Price range $21.90 - $35.41
Increased shares by 12.9% (+1.43M shares) Q4 2025
Avg closing price $25.51
Price range $20.60 - $30.62
Increased shares by 24.8% (+2.19M shares) Q3 2025
Avg closing price $19.84
Price range $16.01 - $25.10
Increased shares by 4.3% (+368k shares) Q2 2025
Avg closing price $17.40
Price range $14.54 - $20.24
Increased shares by 20.0% (+1.41M shares) Q1 2025
Avg closing price $26.26
Price range $19.53 - $34.09
Increased shares by 8.2% (+537k shares) Q4 2024
Avg closing price $25.65
Price range $21.55 - $30.35
Sold 14.4% shares (-1.1M shares) Q3 2024
Avg closing price $25.81
Price range $22.57 - $33.14
Sold 6.8% shares (-556k shares) Q2 2024
Avg closing price $24.56
Price range $21.22 - $32.66
Sold 12.9% shares (-1.21M shares) Q1 2024
Avg closing price $31.16
Price range $23.46 - $45.07
Increased shares by 6.9% (+610k shares) Q4 2023
Avg closing price $24.84
Price range $17.69 - $30.76
Increased shares by 4.8% (+401k shares) Q3 2023
Avg closing price $26.81
Price range $23.01 - $32.46
Sold 2.2% shares (-191k shares) Q2 2023
Avg closing price $32.45
Price range $29.32 - $35.99
Increased shares by 4.4% (+360k shares) Q1 2023
Avg closing price $39.47
Price range $30.15 - $48.79
Sold 3.3% shares (-278k shares) Q4 2022
Avg closing price $44.79
Price range $36.73 - $51.60
Sold 3.4% shares (-301k shares) Q3 2022
Avg closing price $57.05
Price range $39.79 - $70.31
Increased shares by 7.2% (+591k shares) Q2 2022
Avg closing price $39.75
Price range $29.86 - $62.36
Increased shares by 2.7% (+217k shares) Q1 2022
Avg closing price $65.59
Price range $53.73 - $82.16
Increased shares by 16.7% (+1.14M shares) Q4 2021
Avg closing price $85.62
Price range $68.02 - $99.06
Increased shares by 5.9% (+380k shares) Q3 2021
Avg closing price $100.46
Price range $84.37 - $133.60
Increased shares by 35.2% (+1.68M shares) Q2 2021
Avg closing price $79.68
Price range $64.12 - $128.71

News about Beam Therapeutics Inc and Cathie Wood

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!